Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening and clinical implications for BRCA1 and BRCA2 mutation carriers.

Journal of mammary gland biology and neoplasia - 1 Oct 1998

Plon S E

Abstract excerpt

In this article, we review the history of testing for mutations in breast cancer susceptibility genes and discuss the current state of testing for mutations in BRCA1 and BRCA2 in different clinical settings including at-risk individuals and cancer patients. The risk of breast cancer. other associated malignancies and prognosis in carriers of these mutations are reviewed. A final section includes discussion of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Breast Neoplasms
Share to Chromosomes, Human, Pair 17

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genetic Carrier Screening

Share to Genetic Markers

Share to Genetic Testing

Share to Neoplasm Proteins

Source

Identifiers

PMID: 10819532
DOI: 10.1023/a:1018731914813

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening and clinical implications for BRCA1 and BRCA2 mutation carriers.PMID 10819532Read ↗

Evaluation and management of women with BRCA1/2 mutations.Semantic proximity Read ↗

BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers.Semantic proximity Read ↗

Hereditary breast cancer: an update on risk assessment and genetic testing in 2015.Semantic proximity Read ↗

Clinical Considerations of<i>BRCA1</i>- and<i>BRCA2</i>-Mutation Carriers: A ReviewSemantic proximity Read ↗

Clinically relevant biology of hereditary breast cancer.Semantic proximity Read ↗

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.Semantic proximity Read ↗

Hereditary Breast Cancer: BRCA Mutations and Beyond.Semantic proximity Read ↗

Breast cancer susceptibility testing: past, present and future.Semantic proximity Read ↗

Genetic testing in women with breast cancer: implications for treatment.Semantic proximity Read ↗

Breast cancer susceptibility genes. BRCA1 and BRCA2.Semantic proximity Read ↗

Breast cancer genetics and risk assessment: an overview for the clinician.Semantic proximity Read ↗

BRCA1 and BRCA2 - update and implications on the genetics of breast cancer: a clinical perspective.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.